Free Trial

Hyliion (HYLN) Financials

Hyliion logo
$4.59 +0.90 (+24.42%)
As of 01:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Hyliion

Annual Income Statements for Hyliion

This table shows Hyliion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-14 324 -96 -153 -124 -52 -57
Consolidated Net Income / (Loss)
-14 324 -96 -153 -124 -52 -57
Net Income / (Loss) Continuing Operations
-14 324 -96 -153 -124 -52 -57
Total Pre-Tax Income
-14 324 -96 -153 -124 -52 -57
Total Revenue
-3.26 -16 0.98 7.83 14 14 12
Net Interest Income / (Expense)
-3.26 -5.46 0.78 5.72 14 12 8.35
Total Interest Income
0.00 0.01 0.78 5.72 14 12 8.35
Investment Securities Interest Income
0.00 0.01 0.78 5.72 14 12 8.35
Total Interest Expense
3.26 5.47 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income
0.00 -10 0.20 2.11 0.67 1.51 3.49
Service Charges on Deposit Accounts
- - - 0.00 - 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments
0.00 -10 0.00 - 0.00 0.00 0.01
Other Non-Interest Income
0.00 0.00 0.20 2.11 0.67 1.51 3.48
Total Non-Interest Expense
11 -340 97 161 138 66 69
Marketing Expense
9.27 13 58 110 82 37 42
Other Operating Expenses
2.73 9.59 38 51 44 26 26
Restructuring Charge
- - - 0.00 11 3.01 0.50
Nonoperating Income / (Expense), net
- -0.01 - -0.03 - 0.03 0.00
Basic Earnings per Share
($0.16) $3.11 ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Weighted Average Basic Shares Outstanding
86.64M 104.32M 172.22M 175.40M 181.41M 174.92M 175.43M
Diluted Earnings per Share
($0.16) ($0.35) ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Weighted Average Diluted Shares Outstanding
86.64M 112.57M 172.22M 175.40M 181.41M 174.92M 175.43M
Weighted Average Basic & Diluted Shares Outstanding
86.64M 170.26M 173.57M 179.99M 183.21M 174.82M 177.81M

Quarterly Income Statements for Hyliion

This table shows Hyliion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Consolidated Net Income / (Loss)
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Net Income / (Loss) Continuing Operations
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Total Pre-Tax Income
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Total Revenue
3.63 3.46 3.40 3.13 2.98 4.22 2.96 3.72 2.72 2.44 4.32
Net Interest Income / (Expense)
3.53 3.46 3.40 3.13 2.98 2.71 2.47 2.21 1.96 1.71 1.49
Total Interest Income
3.53 3.46 3.40 3.13 2.98 2.71 2.47 2.21 1.96 1.71 1.49
Investment Securities Interest Income
3.53 3.46 3.40 3.13 2.98 2.71 2.47 2.21 1.96 1.71 1.49
Total Interest Expense
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income
0.10 - 0.00 0.00 0.00 1.51 0.49 1.52 0.76 0.73 2.83
Service Charges on Deposit Accounts
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Other Non-Interest Income
0.10 - 0.00 0.00 0.00 1.51 0.49 1.52 0.76 0.71 2.83
Total Non-Interest Expense
34 33 19 14 14 19 20 17 16 16 16
Marketing Expense
25 8.77 7.97 8.31 9.46 11 12 10 10 9.96 7.67
Other Operating Expenses
8.86 12 6.59 6.26 5.65 7.30 6.56 7.35 5.99 6.17 8.80
Restructuring Charge
0.00 11 4.43 -0.56 -0.93 0.06 1.42 -0.35 -0.07 -0.51 -0.41
Basic Earnings per Share
($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Weighted Average Basic Shares Outstanding
181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Diluted Earnings per Share
($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Weighted Average Diluted Shares Outstanding
181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Weighted Average Basic & Diluted Shares Outstanding
182.79M 183.21M 174.04M 173.58M 173.73M 174.82M 175.23M 175.44M 175.97M 177.81M 178.33M

Annual Cash Flow Statements for Hyliion

This table details how cash moves in and out of Hyliion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
5.19 383 -131 -139 -99 -12 14
Net Cash From Operating Activities
-11 -23 -81 -117 -117 -57 -47
Net Cash From Continuing Operating Activities
-11 -23 -81 -117 -117 -57 -47
Net Income / (Loss) Continuing Operations
-14 324 -96 -153 -124 -52 -57
Consolidated Net Income / (Loss)
-14 324 -96 -153 -124 -52 -57
Depreciation Expense
1.03 0.85 0.88 1.23 3.51 3.15 5.96
Amortization Expense
2.49 4.24 1.82 1.25 -2.87 -3.08 -1.56
Non-Cash Adjustments to Reconcile Net Income
0.22 -351 5.83 36 8.85 9.87 7.81
Changes in Operating Assets and Liabilities, net
-0.69 -1.60 7.02 -1.84 -2.95 -15 -1.57
Net Cash From Investing Activities
-0.35 -238 -66 -22 18 59 61
Net Cash From Continuing Investing Activities
-0.35 -238 -66 -22 18 59 61
Purchase of Property, Leasehold Improvements and Equipment
-0.35 -0.31 -2.38 -2.89 -7.40 -17 -24
Purchase of Investment Securities
0.00 -238 -318 -283 -190 -96 -46
Sale of Property, Leasehold Improvements and Equipment
0.00 0.02 0.05 0.15 0.00 5.39 2.23
Sale and/or Maturity of Investments
0.00 0.00 254 264 215 167 129
Other Investing Activities, net
0.00 0.00 -0.03 0.00 -0.05 0.00 0.04
Net Cash From Financing Activities
17 645 16 -0.08 -0.02 -14 -0.67
Net Cash From Continuing Financing Activities
17 645 16 -0.08 -0.02 -14 -0.67
Repurchase of Common Equity
- - - 0.00 -0.03 -14 0.00
Other Financing Activities, Net
0.01 516 0.59 -0.08 0.02 -0.35 -0.67

Quarterly Cash Flow Statements for Hyliion

This table details how cash moves in and out of Hyliion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-20 -7.80 -6.08 4.42 8.93 -19 3.11 3.26 2.29 5.06 -2.68
Net Cash From Operating Activities
-29 -25 -23 -11 -9.90 -13 -14 -10.00 -11 -12 -13
Net Cash From Continuing Operating Activities
-29 -25 -23 -11 -9.90 -13 -14 -10.00 -11 -12 -13
Net Income / (Loss) Continuing Operations
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Consolidated Net Income / (Loss)
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Depreciation Expense
0.66 1.72 0.57 0.71 0.86 1.01 1.14 1.29 1.64 1.89 2.11
Amortization Expense
-1.03 -1.05 -0.97 -0.87 -0.65 -0.59 -0.58 -0.42 -0.27 -0.30 -0.25
Non-Cash Adjustments to Reconcile Net Income
2.58 1.62 6.39 1.39 0.51 1.58 3.13 1.55 1.75 1.39 1.54
Changes in Operating Assets and Liabilities, net
-0.73 2.31 -13 -1.08 0.60 -1.05 -0.45 1.00 -0.47 -1.65 -4.39
Net Cash From Investing Activities
9.10 17 28 18 19 -5.37 18 13 13 17 10
Net Cash From Continuing Investing Activities
9.10 17 28 18 19 -5.37 18 13 13 17 10
Purchase of Property, Leasehold Improvements and Equipment
-2.80 -0.65 -2.82 -5.24 -2.49 -5.98 -7.33 -4.24 -10 -1.74 -1.87
Purchase of Investment Securities
-71 -19 -24 -8.92 -23 -41 0.00 -18 -18 -10 -15
Sale of Property, Leasehold Improvements and Equipment
- - 0.57 2.90 0.64 1.28 0.22 0.58 0.39 1.04 1.60
Sale and/or Maturity of Investments
83 37 54 29 43 40 25 35 41 28 26
Other Investing Activities, net
- - 0.00 - - - 0.04 - - - 0.00
Net Cash From Financing Activities
0.13 -0.01 -11 -3.01 -0.01 -0.02 -0.44 -0.09 -0.06 -0.08 0.00
Net Cash From Continuing Financing Activities
0.13 -0.01 -11 -3.01 -0.01 -0.02 -0.44 -0.09 -0.06 -0.08 0.00
Other Financing Activities, Net
0.13 0.02 -0.25 -0.07 -0.01 -0.02 -0.44 -0.09 -0.06 -0.08 0.00

Annual Balance Sheets for Hyliion

This table presents Hyliion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
0.40 14 655 578 447 328 263 204
Cash and Due from Banks
0.00 6.29 390 258 119 13 9.23 23
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
- 1.64 1.17 2.24 5.61 9.99 26 40
Other Assets
0.00 5.75 264 318 321 306 228 140
Total Liabilities & Shareholders' Equity
0.40 14 655 578 447 328 263 204
Total Liabilities
0.38 32 15 25 23 22 19 12
Short-Term Debt
0.07 7.88 2.62 7.46 3.15 5.07 7.67 5.87
Accrued Interest Payable
0.30 - - - 12 - 6.62 4.00
Other Long-Term Liabilities
0.00 5.30 5.25 17 8.49 7.00 4.37 1.69
Commitments & Contingencies
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.02 -18 640 554 424 306 244 192
Total Preferred & Common Equity
0.02 -18 640 554 424 306 244 192
Total Common Equity
0.02 -18 640 554 424 306 244 192
Common Stock
0.03 31 365 375 398 404 408 413
Retained Earnings
-0.00 -49 275 179 26 -98 -150 -207
Treasury Stock
- - - - 0.00 -0.03 -14 -14

Quarterly Balance Sheets for Hyliion

This table presents Hyliion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
391 356 298 281 272 241 229 216 191
Cash and Due from Banks
48 29 15 19 28 12 16 18 20
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
8.94 11 13 16 17 29 33 42 38
Other Assets
334 316 270 246 227 199 181 157 132
Total Liabilities & Shareholders' Equity
391 356 298 281 272 241 229 216 191
Total Liabilities
28 22 17 14 15 13 13 12 9.03
Short-Term Debt
2.86 4.31 3.56 2.03 3.19 4.00 5.26 4.70 3.71
Accrued Interest Payable
- - 6.95 5.49 5.98 5.24 5.00 5.29 4.37
Other Long-Term Liabilities
9.34 8.60 6.74 6.01 5.40 3.75 3.08 2.39 0.95
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
363 334 280 268 258 228 216 204 182
Total Preferred & Common Equity
363 334 280 268 258 228 216 204 182
Total Common Equity
363 334 280 268 258 228 216 204 182
Common Stock
401 403 405 406 407 409 410 412 415
Retained Earnings
-38 -69 -113 -124 -135 -167 -180 -194 -219
Treasury Stock
- - -11 -14 -14 -14 -14 -14 -14

Annual Metrics And Ratios for Hyliion

This table displays calculated financial ratios and metrics derived from Hyliion's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
29,126,147.00 153,901,829.00 173,313,427.00 179,714,124.00 182,789,454.00 - 175,974,228.00
DEI Adjusted Shares Outstanding
29,126,147.00 153,901,829.00 173,313,427.00 179,714,124.00 182,789,454.00 - 175,974,228.00
DEI Earnings Per Adjusted Shares Outstanding
-0.48 2.11 -0.55 -0.85 -0.68 - -0.33
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -379.42% 106.26% 699.80% 84.94% -5.20% -13.75%
EBITDA Growth
0.00% 3,197.92% -128.35% -61.58% 18.51% 57.69% -1.51%
EBIT Growth
0.00% 2,392.28% -129.63% -59.61% 19.40% 57.85% -9.81%
NOPAT Growth
0.00% 3,374.69% -120.74% -59.61% 19.40% 57.85% -9.81%
Net Income Growth
0.00% 2,396.58% -129.63% -59.67% 19.46% 57.86% -9.88%
EPS Growth
0.00% -118.75% -60.00% -55.36% 21.84% 55.88% -10.00%
Operating Cash Flow Growth
0.00% -107.23% -250.86% -45.19% -0.07% 51.49% 17.96%
Free Cash Flow Firm Growth
0.00% 0.00% 104.72% 81.07% 5.70% -21.01% -38.00%
Invested Capital Growth
0.00% 126,068.69% -12.79% -23.99% -27.04% -19.04% -21.50%
Revenue Q/Q Growth
0.00% 0.00% 110.19% 77.71% -2.55% 5.85% -13.08%
EBITDA Q/Q Growth
0.00% 0.00% -133.68% -0.05% 0.39% 21.82% 4.32%
EBIT Q/Q Growth
0.00% 0.00% -134.93% 0.19% 0.14% 22.09% 2.08%
NOPAT Q/Q Growth
0.00% 0.00% -124.33% 0.19% 0.14% 22.03% 2.08%
Net Income Q/Q Growth
0.00% 0.00% -134.75% 0.16% 0.21% 22.06% 2.08%
EPS Q/Q Growth
0.00% 0.00% -7.69% 2.25% 0.00% 18.92% 5.71%
Operating Cash Flow Q/Q Growth
0.00% -9.13% -30.30% -2.41% 7.07% 16.35% 3.30%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 117.56% -4.83% 1.19% -26.39% 23.26%
Invested Capital Q/Q Growth
0.00% 182.62% -4.87% -5.98% -8.07% -3.39% -5.12%
Profitability Metrics
- - - - - - -
EBITDA Margin
0.00% 0.00% -9,535.04% -1,926.30% -848.82% -378.87% -445.90%
EBIT Margin
0.00% 0.00% -9,810.83% -1,957.93% -853.26% -379.37% -483.01%
Profit (Net Income) Margin
0.00% 0.00% -9,810.83% -1,958.58% -852.91% -379.14% -483.01%
Tax Burden Percent
99.81% 100.00% 100.00% 100.01% 99.96% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.02% 100.00% 99.94% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% -11.16% -21.72% -23.44% -12.94% -17.79%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -535.68% -890.29% -924.34% -257.71% -271.27%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% -4.93% -9.66% -10.41% -5.96% -8.41%
Return on Equity (ROE)
78.11% 104.20% -16.09% -31.38% -33.85% -18.90% -26.21%
Cash Return on Invested Capital (CROIC)
0.00% -49.73% 2.51% 5.53% 7.83% 8.10% 6.29%
Operating Return on Assets (OROA)
0.00% 0.00% -15.57% -29.91% -31.88% -17.61% -24.51%
Return on Assets (ROA)
0.00% 0.00% -15.57% -29.92% -31.87% -17.60% -24.51%
Return on Common Equity (ROCE)
78.11% 104.20% -16.09% -31.38% -33.85% -18.90% -26.21%
Return on Equity Simple (ROE_SIMPLE)
78.11% 50.63% -17.34% -36.21% -40.33% -21.30% -29.78%
Net Operating Profit after Tax (NOPAT)
-9.90 324 -67 -107 -86 -36 -40
NOPAT Margin
0.00% 0.00% -6,867.58% -1,370.55% -597.28% -265.56% -338.10%
Net Nonoperating Expense Percent (NNEP)
24.01% 0.11% 524.52% 868.57% 900.90% 244.77% 253.47%
SG&A Expenses to Revenue
0.00% 0.00% 5,951.07% 1,409.58% 567.92% 269.55% 358.67%
Operating Expenses to Revenue
0.00% 0.00% 9,910.83% 2,057.93% 953.26% 479.37% 583.01%
Earnings before Interest and Taxes (EBIT)
-14 324 -96 -153 -124 -52 -57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-11 329 -93 -151 -123 -52 -53
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 3.96 1.94 0.99 0.49 1.86 1.69
Price to Tangible Book Value (P/TBV)
0.00 3.96 1.94 0.99 0.49 1.86 1.69
Price to Revenue (P/Rev)
0.00 0.00 1,097.59 53.71 10.27 33.03 27.35
Price to Earnings (P/E)
0.00 7.83 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 12.78% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 3.34 1.47 0.71 0.45 1.79 1.55
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 841.22 38.85 9.73 32.92 25.91
Enterprise Value to EBITDA (EV/EBITDA)
0.00 6.53 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 6.63 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 6.63 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 54.55 11.13 4.88 19.80 21.68
Leverage & Solvency
- - - - - - -
Debt to Equity
-0.97 0.01 0.01 0.01 0.02 0.03 0.03
Long-Term Debt to Equity
-0.54 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.97 0.03 0.01 0.01 0.01 0.02 0.03
Leverage Ratio
-0.78 1.08 1.03 1.05 1.06 1.07 1.07
Compound Leverage Factor
-0.78 1.08 1.03 1.05 1.06 1.07 1.07
Debt to Total Capital
-3,436.01% 0.55% 1.33% 0.74% 1.63% 3.04% 2.97%
Short-Term Debt to Total Capital
-1,541.29% 0.41% 1.33% 0.74% 1.63% 3.04% 2.97%
Long-Term Debt to Total Capital
-1,894.72% 0.14% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
3,536.01% 99.45% 98.67% 99.26% 98.37% 96.96% 97.03%
Debt to EBITDA
-1.65 0.01 -0.08 -0.02 -0.04 -0.15 -0.11
Net Debt to EBITDA
-1.06 -1.17 2.69 0.77 0.06 0.03 0.32
Long-Term Debt to EBITDA
-0.91 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-1.77 0.01 -0.11 -0.03 -0.06 -0.21 -0.15
Net Debt to NOPAT
-1.14 -1.19 3.73 1.08 0.09 0.04 0.43
Long-Term Debt to NOPAT
-0.98 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -320 15 27 29 23 14
Operating Cash Flow to CapEx
-3,172.49% -7,939.10% -3,447.62% -4,276.51% -1,580.78% -509.32% -216.45%
Free Cash Flow to Firm to Interest Expense
0.00 -58.57 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-3.40 -4.20 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-3.50 -4.25 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.00 0.00 0.02 0.04 0.05 0.05
Fixed Asset Turnover
0.00 0.00 0.57 2.00 1.86 0.76 0.36
Capital & Investment Metrics
- - - - - - -
Invested Capital
-0.51 644 561 427 311 252 198
Invested Capital Turnover
0.00 0.00 0.00 0.02 0.04 0.05 0.05
Increase / (Decrease) in Invested Capital
0.00 644 -82 -135 -115 -59 -54
Enterprise Value (EV)
302 2,150 824 304 141 452 307
Market Capitalization
291 2,536 1,075 421 149 453 324
Book Value per Share
($0.62) $4.16 $3.20 $2.36 $1.68 $1.41 $1.09
Tangible Book Value per Share
($0.64) $4.16 $3.19 $2.36 $1.68 $1.41 $1.09
Total Capital
-0.51 644 561 427 311 252 198
Total Debt
18 3.53 7.46 3.15 5.07 7.67 5.87
Total Long-Term Debt
9.68 0.91 0.00 0.00 0.00 0.00 0.00
Net Debt
11 -386 -251 -116 -7.81 -1.56 -17
Capital Expenditures (CapEx)
0.35 0.29 2.34 2.73 7.40 11 22
Net Nonoperating Expense (NNE)
4.22 0.01 29 46 37 16 17
Net Nonoperating Obligations (NNO)
18 3.53 7.46 3.15 5.07 7.67 5.87
Total Depreciation and Amortization (D&A)
3.51 5.09 2.70 2.48 0.64 0.07 4.39
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 172.22M 175.40M 181.41M 174.92M 175.43M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 172.22M 175.40M 181.41M 174.92M 175.43M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 173.57M 179.99M 183.21M 174.82M 177.81M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -26 -67 -107 -78 -34 -40
Normalized NOPAT Margin
0.00% 0.00% -6,815.38% -1,370.55% -541.81% -250.23% -335.15%
Pre Tax Income Margin
0.00% 0.00% -9,810.83% -1,958.34% -853.26% -379.14% -483.01%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-4.34 59.31 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-3.04 59.31 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-4.44 59.26 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-3.14 59.26 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -0.03% -26.86% 0.00%

Quarterly Metrics And Ratios for Hyliion

This table displays calculated financial ratios and metrics derived from Hyliion's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
181,220,377.00 182,789,454.00 182,789,454.00 174,035,799.00 173,583,438.00 - 174,820,174.00 175,232,794.00 175,436,636.00 175,974,228.00 177,812,784.00
DEI Adjusted Shares Outstanding
181,220,377.00 182,789,454.00 182,789,454.00 174,035,799.00 173,583,438.00 - 174,820,174.00 175,232,794.00 175,436,636.00 175,974,228.00 177,812,784.00
DEI Earnings Per Adjusted Shares Outstanding
-0.17 -0.16 -0.09 -0.06 -0.06 - -0.10 -0.08 -0.08 -0.07 -0.07
Growth Metrics
- - - - - - - - - - -
Revenue Growth
46.90% -9.86% -9.94% -13.42% -17.93% 21.89% -13.00% 19.02% -8.73% -42.19% 46.16%
EBITDA Growth
51.14% 1.67% 43.86% 68.65% 64.20% 50.94% -4.34% -13.62% -8.80% 17.05% 40.82%
EBIT Growth
52.12% 0.58% 45.89% 69.09% 63.09% 50.63% -10.66% -23.20% -19.06% 8.44% 31.98%
NOPAT Growth
52.12% 0.59% 45.89% 69.09% 63.09% 50.68% -10.66% -23.20% -19.06% 8.44% 31.98%
Net Income Growth
52.16% 0.87% 45.92% 69.18% 63.06% 50.57% -10.66% -23.56% -19.06% 8.44% 31.98%
EPS Growth
52.78% 0.00% 43.75% 68.42% 64.71% 43.75% -11.11% -33.33% -33.33% 22.22% 30.00%
Operating Cash Flow Growth
-3.47% 26.62% 31.70% 64.76% 65.69% 45.19% 38.31% 6.54% -8.05% 11.82% 9.13%
Free Cash Flow Firm Growth
2.23% -16.78% -5.45% -18.64% -25.55% -48.18% -62.08% -55.54% -38.47% -8.63% -3.91%
Invested Capital Growth
-25.38% -27.04% -29.02% -26.27% -22.96% -19.04% -18.30% -18.06% -20.07% -21.50% -20.07%
Revenue Q/Q Growth
0.44% -4.60% -1.85% -7.94% -4.79% 41.69% -29.95% 25.94% -26.99% -10.26% 77.13%
EBITDA Q/Q Growth
12.78% 7.22% 43.88% 30.96% 0.40% -27.13% -19.36% 24.82% 4.62% 3.08% 14.85%
EBIT Q/Q Growth
13.86% 3.89% 46.54% 30.17% -2.88% -28.53% -19.84% 22.26% 0.57% 1.15% 10.97%
NOPAT Q/Q Growth
13.86% 3.80% 46.59% 30.17% -2.88% -28.53% -19.84% 22.26% 0.57% 1.15% 10.97%
Net Income Q/Q Growth
13.92% 3.93% 46.47% 30.37% -3.19% -28.53% -19.84% 22.26% 0.57% 1.15% 10.97%
EPS Q/Q Growth
10.53% 5.88% 43.75% 33.33% 0.00% -50.00% -11.11% 20.00% 0.00% 12.50% 0.00%
Operating Cash Flow Q/Q Growth
4.98% 14.92% 7.47% 52.89% 7.47% -35.90% -4.14% 28.63% -6.97% -10.91% -7.32%
Free Cash Flow Firm Q/Q Growth
-13.66% 1.09% 10.81% -15.87% -21.00% -29.63% -18.90% -1.38% 9.34% 4.48% -14.71%
Invested Capital Q/Q Growth
-7.47% -8.07% -8.79% -4.96% -3.32% -3.39% -7.96% -4.68% -5.69% -5.12% -6.29%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
-846.17% -822.93% -470.52% -352.86% -369.15% -331.20% -564.32% -336.87% -440.05% -475.29% -228.48%
EBIT Margin
-836.03% -842.22% -458.72% -347.97% -376.03% -341.10% -583.50% -360.20% -490.51% -540.29% -271.56%
Profit (Net Income) Margin
-835.32% -841.18% -458.72% -346.95% -376.03% -341.10% -583.50% -360.20% -490.51% -540.29% -271.56%
Tax Burden Percent
100.00% 99.78% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
99.91% 100.10% 100.00% 99.71% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-21.95% -23.16% -13.24% -10.44% -11.39% -11.64% -21.04% -14.26% -19.92% -19.90% -12.03%
ROIC Less NNEP Spread (ROIC-NNEP)
-284.40% -234.73% -146.19% -142.91% -101.02% -79.44% -158.06% -124.71% -121.46% -78.34% -103.43%
Return on Net Nonoperating Assets (RNNOA)
-2.50% -2.64% -1.52% -1.11% -1.28% -1.84% -2.35% -1.88% -2.07% -2.43% -1.95%
Return on Equity (ROE)
-24.45% -25.80% -14.76% -11.54% -12.67% -13.47% -23.38% -16.14% -22.00% -22.33% -13.97%
Cash Return on Invested Capital (CROIC)
7.21% 7.83% 11.37% 11.31% 10.33% 8.10% 5.57% 3.81% 4.89% 6.29% 4.98%
Operating Return on Assets (OROA)
-29.83% -31.47% -18.06% -14.10% -15.52% -15.84% -28.79% -19.59% -27.35% -27.42% -16.61%
Return on Assets (ROA)
-29.80% -31.43% -18.06% -14.06% -15.52% -15.84% -28.79% -19.59% -27.35% -27.42% -16.61%
Return on Common Equity (ROCE)
-24.45% -25.80% -14.76% -11.54% -12.67% -13.47% -23.38% -16.14% -22.00% -22.33% -13.97%
Return on Equity Simple (ROE_SIMPLE)
-37.02% 0.00% -39.32% -32.07% -25.91% 0.00% -23.56% -26.07% -28.65% 0.00% -28.43%
Net Operating Profit after Tax (NOPAT)
-21 -20 -11 -7.62 -7.84 -10 -12 -9.39 -9.34 -9.23 -8.22
NOPAT Margin
-585.22% -590.14% -321.11% -243.58% -263.22% -238.77% -408.45% -252.14% -343.36% -378.20% -190.09%
Net Nonoperating Expense Percent (NNEP)
262.46% 211.57% 132.94% 132.48% 89.63% 67.81% 137.03% 110.45% 101.54% 58.43% 91.40%
SG&A Expenses to Revenue
691.87% 253.19% 234.42% 265.61% 317.62% 266.83% 413.59% 272.21% 372.78% 408.36% 177.46%
Operating Expenses to Revenue
936.03% 942.22% 558.72% 447.97% 476.03% 441.10% 683.50% 460.20% 590.51% 640.29% 371.56%
Earnings before Interest and Taxes (EBIT)
-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-31 -28 -16 -11 -11 -14 -17 -13 -12 -12 -9.88
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.64 0.49 1.15 1.05 1.67 1.86 1.07 1.07 1.70 1.69 1.72
Price to Tangible Book Value (P/TBV)
0.64 0.49 1.15 1.05 1.67 1.86 1.07 1.07 1.70 1.69 1.72
Price to Revenue (P/Rev)
14.39 10.27 22.81 20.70 33.19 33.03 18.42 16.66 25.37 27.35 23.70
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.56 0.45 1.09 0.98 1.55 1.79 1.02 1.00 1.59 1.55 1.60
Enterprise Value to Revenue (EV/Rev)
12.76 9.73 22.02 19.44 31.27 32.92 17.79 15.92 24.41 25.91 22.45
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
6.64 4.88 7.99 7.37 13.10 19.80 16.44 23.63 28.96 21.68 28.53
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.01 0.02 0.01 0.01 0.01 0.03 0.02 0.02 0.02 0.03 0.02
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.02 0.03 0.02
Leverage Ratio
1.06 1.06 1.06 1.07 1.06 1.07 1.06 1.06 1.06 1.07 1.05
Compound Leverage Factor
1.06 1.06 1.06 1.06 1.06 1.07 1.06 1.06 1.06 1.07 1.05
Debt to Total Capital
1.27% 1.63% 1.25% 0.75% 1.22% 3.04% 1.72% 2.38% 2.25% 2.97% 2.00%
Short-Term Debt to Total Capital
1.27% 1.63% 1.25% 0.75% 1.22% 3.04% 1.72% 2.38% 2.25% 2.97% 2.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
98.73% 98.37% 98.75% 99.25% 98.78% 96.96% 98.28% 97.62% 97.75% 97.03% 98.00%
Debt to EBITDA
-0.04 -0.04 -0.03 -0.02 -0.05 -0.15 -0.08 -0.10 -0.09 -0.11 -0.08
Net Debt to EBITDA
0.20 0.06 0.10 0.20 0.37 0.03 0.16 0.19 0.24 0.32 0.36
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.05 -0.06 -0.05 -0.03 -0.07 -0.21 -0.11 -0.13 -0.11 -0.15 -0.10
Net Debt to NOPAT
0.28 0.09 0.14 0.28 0.53 0.04 0.22 0.26 0.32 0.43 0.46
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
94 95 105 89 70 49 40 39 43 45 38
Operating Cash Flow to CapEx
-1,028.83% -3,797.99% -1,010.77% -457.40% -533.71% -285.98% -196.82% -273.09% -106.54% -1,706.19% -4,610.87%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.06 0.05 0.06
Fixed Asset Turnover
1.76 1.86 1.34 1.10 0.91 0.76 0.63 0.57 0.46 0.36 0.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
339 311 284 270 261 252 232 221 209 198 185
Invested Capital Turnover
0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.06 0.06 0.05 0.06
Increase / (Decrease) in Invested Capital
-115 -115 -116 -96 -78 -59 -52 -49 -52 -54 -47
Enterprise Value (EV)
190 141 311 265 406 452 236 221 332 307 296
Market Capitalization
214 149 322 282 430 453 245 231 346 324 313
Book Value per Share
$1.85 $1.68 $1.57 $1.54 $1.48 $1.41 $1.30 $1.23 $1.16 $1.09 $1.02
Tangible Book Value per Share
$1.84 $1.68 $1.57 $1.54 $1.48 $1.41 $1.30 $1.23 $1.16 $1.09 $1.02
Total Capital
339 311 284 270 261 252 232 221 209 198 185
Total Debt
4.31 5.07 3.56 2.03 3.19 7.67 4.00 5.26 4.70 5.87 3.71
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-24 -7.81 -11 -17 -25 -1.56 -8.33 -10 -13 -17 -17
Capital Expenditures (CapEx)
2.80 0.65 2.25 2.34 1.85 4.70 7.12 3.66 10 0.70 0.28
Net Nonoperating Expense (NNE)
9.08 8.69 4.68 3.23 3.36 4.32 5.18 4.02 4.00 3.95 3.52
Net Nonoperating Obligations (NNO)
4.31 5.07 3.56 2.03 3.19 7.67 4.00 5.26 4.70 5.87 3.71
Total Depreciation and Amortization (D&A)
-0.37 0.67 -0.40 -0.15 0.21 0.42 0.57 0.87 1.37 1.59 1.86
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Adjusted Weighted Average Basic Shares Outstanding
181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Adjusted Diluted Earnings per Share
($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding
181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
182.79M 183.21M 174.04M 173.58M 173.73M 174.82M 175.23M 175.44M 175.97M 177.81M 178.33M
Normalized Net Operating Profit after Tax (NOPAT)
-21 -12 -7.81 -8.01 -8.49 -10 -11 -9.63 -9.38 -9.58 -8.51
Normalized NOPAT Margin
-585.22% -358.21% -229.85% -256.02% -285.05% -237.76% -374.76% -258.65% -345.16% -392.77% -196.80%
Pre Tax Income Margin
-835.32% -843.06% -458.72% -346.95% -376.03% -341.10% -583.50% -360.20% -490.51% -540.29% -271.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -0.03% -10.04% -16.32% -20.99% -26.86% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Hyliion’s latest quarter shows a business that is still deeply unprofitable, but with a very large cash cushion and balance sheet flexibility. In Q1 2026, revenue was just $4.3 million while net loss came in at $11.7 million. The company also burned $12.7 million in operating cash during the quarter. That said, Hyliion ended the quarter with $20.3 million in cash and $181.7 million in total equity, and it continued to generate meaningful interest income from its investment portfolio.

  • Large cash and investments buffer remains in place. Hyliion reported $20.3 million in cash at the end of Q1 2026, and the quarter also included $25.5 million of sales/maturities of investments, helping support liquidity.
  • Balance sheet remains clean with very low debt. Total liabilities were only $9.0 million versus $190.8 million in assets, indicating leverage is not a major near-term issue.
  • Equity remains substantial. Total common equity stood at $181.7 million in Q1 2026, giving the company a sizable capital base despite ongoing losses.
  • Interest income continues to help offset losses. Hyliion generated $1.5 million of interest income in Q1 2026, which remains an important source of non-operating support.
  • Operating cash burn improved from a year earlier. Net cash used in operating activities was $12.7 million in Q1 2026, better than the $14.0 million used in Q1 2025 and far better than the larger burn seen in 2024.
  • Revenue remains small and volatile. Q1 2026 revenue of $4.3 million was modest and below the prior quarter’s $2.4 million only slightly in context, but still far from a scale business.
  • The company is still heavily dependent on investment income and portfolio activity. Most revenue is coming from interest income and other non-core items rather than product sales.
  • Capital spending is modest but ongoing. Hyliion spent $1.9 million on property, leasehold improvements and equipment in Q1 2026, suggesting continued investment in operations.
  • Hyliion remains unprofitable. The company posted a $11.7 million net loss in Q1 2026, extending a long streak of quarterly losses.
  • Operating losses are still significant relative to revenue. Non-interest expenses of $16.1 million were far above total revenue of $4.3 million, showing the business is not yet near break-even.
  • Marketing and operating costs remain elevated. Q1 2026 marketing expense was $7.7 million and other operating expenses were $8.8 million, both sizable for a company with limited revenue.
  • Cash declined during the quarter. Net change in cash and equivalents was negative $2.7 million, so despite investment gains the company is still consuming liquidity.
  • Longer-term trend still points to persistent losses. Over the last several years, Hyliion has repeatedly posted quarterly losses, with losses ranging from roughly $10.9 million to $35.2 million in the periods shown, indicating a difficult path to profitability.

Bottom line: Hyliion’s financial position is supported by cash, investments, and a low-debt balance sheet, which lowers near-term financing risk. But the core business is still not producing meaningful revenue, and operating losses remain substantial. For retail investors, the key question is whether the company can convert its cash runway and assets into a scalable commercial business before the burn rate becomes a bigger problem.

05/15/26 01:57 PM ETAI Generated. May Contain Errors.

Hyliion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyliion's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Hyliion's net income appears to be on an upward trend, with a most recent value of -$57.19 million in 2025, rising from -$14.11 million in 2019. The previous period was -$52.05 million in 2024. See where experts think Hyliion is headed by visiting Hyliion's forecast page.

Over the last 6 years, Hyliion's total revenue changed from -$3.26 million in 2019 to $11.84 million in 2025, a change of -463.2%.

Hyliion's total liabilities were at $11.55 million at the end of 2025, a 38.1% decrease from 2024, and a 2,974.0% increase since 2018.

In the past 7 years, Hyliion's cash and equivalents has ranged from $0.00 in 2018 to $389.71 million in 2020, and is currently $22.94 million as of their latest financial filing in 2025.

Over the last 6 years, Hyliion's book value per share changed from -0.62 in 2019 to 1.09 in 2025, a change of -275.9%.



Financial statements for NYSE:HYLN last updated on 5/15/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners